Cargando…

OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer

Gastric cancer is one of the most lethal human malignancies in the world. Although great efforts are put in developing novel therapeutic targets, the effective targeting drugs are still limited. Recent studies reveal the abnormality of Hippo/YAP axis play critical role in the oncogenic process of ga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Cheng, Yang, Huijie, Su, Peng, Li, Xin, Li, Zhongbo, Wang, Dehai, Zang, Yifeng, Wang, Tianshi, Liu, Ziping, Bao, Zhuocong, Dong, Shuxiao, Zhuang, Ting, Zhu, Jian, Ding, Yinlu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700521/ https://www.ncbi.nlm.nih.gov/pubmed/36271031 http://dx.doi.org/10.1038/s41388-022-02507-3

Ejemplares similares

Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer
por: Wang, Tianshi, et al.
Publicado: (2023)

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
por: Wang, Dehai, et al.
Publicado: (2022)

RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
por: Li, Zhongbo, et al.
Publicado: (2022)

Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis
por: Mi, Yushuai, et al.
Publicado: (2022)

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis
por: Liu, Dongyi, et al.
Publicado: (2023)

ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling
por: Liu, Yun, et al.
Publicado: (2021)

RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer
por: Yang, Huijie, et al.
Publicado: (2022)

OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma
por: Liu, Li, et al.
Publicado: (2022)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

DAB2 suppresses gastric cancer migration by regulating the Wnt/β-catenin and Hippo-YAP signaling pathways
por: Wang, Hua, et al.
Publicado: (2020)

Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022)

Totally laparoscopic gastrectomy with natural orifice (vagina) specimen extraction in gastric cancer: Introduction of a new technique
por: Dong, Changzheng, et al.
Publicado: (2022)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
por: Wang, Shuai, et al.
Publicado: (2020)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

SUFU suppresses ferroptosis sensitivity in breast cancer cells via Hippo/YAP pathway
por: Fang, Kun, et al.
Publicado: (2022)

Bazedoxifene enhances paclitaxel efficacy to suppress glioblastoma via altering Hippo/YAP pathway
por: Fu, Weiwei, et al.
Publicado: (2020)

Clinical potential of the Hippo-YAP pathway in bladder cancer
por: Cheng, Xin, et al.
Publicado: (2022)

The mechanism of OTUB1 inhibition of ubiquitination
por: Wiener, Reuven, et al.
Publicado: (2012)

The Hippo/YAP signaling pathway: the driver of cancer metastasis
por: Zhou, Tianxing, et al.
Publicado: (2023)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

Hippo-Yap Pathway Orchestrates Neural Crest Ontogenesis
por: Zhao, Xiaolei, et al.
Publicado: (2021)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

Met1-specific motifs conserved in OTUB subfamily of green plants enable rice OTUB1 to hydrolyse Met1 ubiquitin chains
por: Lu, Lining, et al.
Publicado: (2022)

YAP–VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP
por: Cai, Jing, et al.
Publicado: (2022)

LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism
por: He, Xin-yu, et al.
Publicado: (2023)

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
por: Yang, Xianliang, et al.
Publicado: (2021)

NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression
por: Wang, Lijun, et al.
Publicado: (2021)

MicroRNA-103a Curtails the Stemness of Non-Small Cell Lung Cancer Cells by Binding OTUB1 via the Hippo Signaling Pathway
por: Hu, Zhenzhen, et al.
Publicado: (2020)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

An emerging role for Hippo-YAP signaling in cardiovascular development
por: Zhou, Jiliang
Publicado: (2014)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

The role of Hippo‐YAP signaling in squamous cell carcinomas
por: Maehama, Tomohiko, et al.
Publicado: (2020)

New Insights into Hippo/YAP Signaling in Fibrotic Diseases
por: Mia, Masum M., et al.
Publicado: (2022)

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2022)

Hippo signaling dysfunction induces cancer cell addiction to YAP
por: Han, Han, et al.
Publicado: (2018)

SOX9 promotes epithelial-mesenchymal transition via the Hippo-YAP signaling pathway in gastric carcinoma cells
por: Zhou, Hailang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g6m0ravn6cfdi6mg7r3fe45ta0